Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

John P. Neoptolemos, Deborah Stocken, Helmut Friess et al. · New England Journal of Medicine · 2004 · 2.7K citations

Medicine, Oncology, Surgery +16

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Helmut Oettle, Stefan Post, P. Neuhaus et al. · JAMA · 2007 · 2.4K citations

Medicine, Oncology, Surgery +13

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al. · Journal of Gastrointestinal Surgery · 2000 · 1.5K citations

Medicine, Oncology, Surgery +12

Colorectal carcinoma antigens detected by hybridoma antibodies

Hilary Koprowski, Zenon Steplewski, Kenneth F. Mitchell et al. · Somatic Cell and Molecular Genetics · 1979 · 1.4K citations

Life Sciences, Cancer Biology, Oncology +14

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Douglas B. Evans, Gauri R. Varadhachary, Christopher H. Crane et al. · Journal of Clinical Oncology · 2008 · 731 citations

Medicine, Oncology, Surgery +16